Biotech Stock Nearly 300% Sparks Massive Bet on 2027 Breast Drug
A biotech stock nearly 300% pop grabbed the attention of major investors, culminating in a $68.7 million stake as a b...
Freelancers learn how to determine an appropriate emergency fund length given variable workloads, invoicing cycles, and income gaps.
22,516 articlesA biotech stock nearly 300% pop grabbed the attention of major investors, culminating in a $68.7 million stake as a b...
A leading analyst warns of multi-year shortages coming optical as AI data-center growth strains suppliers. LUMENTUM a...
Nvidia often dominates AI chip discussions, but a lower price doesn’t guarantee gains. This guide breaks down the ris...
XRP has fallen from recent highs, but a rebound back above $2 is on the table if key catalysts align. This guide brea...
A bold contrarian wager on semiconductors has underperformed as AI demand sustains a rally. Leveraged, daily-reset fu...
General Mills faces a turning point in 2026. This in-depth look examines earnings drivers, margins, and cash returns,...
Powell confirms he will remain as chair pro tem if Warsh is not confirmed by mid-May, delivering a clear answer amid ...
Gemini Space Station stock dropped sharply after a downgrade spurred by profitability concerns and cautious guidance....
Disney moved to strengthen its finances ahead of a CEO transition by extending CFO Hugh Johnston's contract, signalin...
Red Cat Holdings faced a sharp one-day re-pricing after mixed quarterly results, underscoring how revenue beats can c...
Criminals are exploiting the Tron network by issuing tokens that imitate government agencies. This guide explains wha...
Analysts see SpaceX, OpenAI, and Anthropic pursuing record mega-IPOs in 2026, potentially reshaping liquidity for ven...